Intensity Therapeutics Statistics
Total Valuation
INTS has a market cap or net worth of $36.05 million. The enterprise value is $37.99 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
INTS has 13.77 million shares outstanding. The number of shares has increased by 129.62% in one year.
Current Share Class | 13.77M |
Shares Outstanding | 13.77M |
Shares Change (YoY) | +129.62% |
Shares Change (QoQ) | +0.67% |
Owned by Insiders (%) | 28.59% |
Owned by Institutions (%) | 12.64% |
Float | 6.34M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 14.72 |
P/TBV Ratio | 14.62 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.05.
Current Ratio | 1.63 |
Quick Ratio | 1.20 |
Debt / Equity | 0.05 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -16,734.49 |
Financial Efficiency
Return on equity (ROE) is -173.98% and return on invested capital (ROIC) is -110.15%.
Return on Equity (ROE) | -173.98% |
Return on Assets (ROA) | -94.96% |
Return on Capital (ROIC) | -110.15% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.32M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.48% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +40.48% |
50-Day Moving Average | 3.49 |
200-Day Moving Average | 4.22 |
Relative Strength Index (RSI) | 36.94 |
Average Volume (20 Days) | 14,388 |
Short Selling Information
The latest short interest is 44,277, so 0.32% of the outstanding shares have been sold short.
Short Interest | 44,277 |
Short Previous Month | 41,124 |
Short % of Shares Out | 0.32% |
Short % of Float | 0.70% |
Short Ratio (days to cover) | 3.05 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -16.73M |
Pretax Income | -15.07M |
Net Income | -16.26M |
EBITDA | n/a |
EBIT | -16.73M |
Earnings Per Share (EPS) | -$1.18 |
Full Income Statement Balance Sheet
The company has $2.78 million in cash and $145,000 in debt, giving a net cash position of $2.64 million or $0.19 per share.
Cash & Cash Equivalents | 2.78M |
Total Debt | 145,000 |
Net Cash | 2.64M |
Net Cash Per Share | $0.19 |
Equity (Book Value) | 2.78M |
Book Value Per Share | 0.20 |
Working Capital | 1.47M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -13.50M |
Capital Expenditures | n/a |
Free Cash Flow | -13.50M |
FCF Per Share | -$0.98 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |